BioNTech SE BNTX
Set alert
87.35 USD -0.18 -0.21%
As of Nov 3, 11:23 AM ET
86.65 Day range 89.88
79.52 52-week range 124.00
- YTD
- -8.25%
- 1 year
- -15.98%
- Open
- 89.79
- Prev close
- 87.53
- Mkt cap
- 21.93B
- Vol
- 433.48K
- Avg vol
- 1.26M
- EPS
- -7.83
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 86.65
- High
- 89.88
- Forward P/E
- -16.19
- Beta
- 1.33
- Short ratio
- 2.35
- Inst. own
- 19.75%
- Dividend
- 0.00
- Ex-div date
- Jun 1, 2022
- Earnings
- Nov 3, 2026
- 50-d avg
- 97.24
- 200-d avg
- 97.10
- 1y target
- 116.89
1M chart
Events in this range
- Oct 7, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 14, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 3, 2026Earnings: —; estimate 0.848; surprise —%
Signals (7)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 116.89 +33.8% upside
Now 87.35
- Target (low)
- 75.97
- Target (mean)
- 116.89
- Target (high)
- 144.15
Ratings (0m) 21 14 buy · 7 hold · 0 sell
- Strong buy1
- Buy13
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 20
- 2 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.75786 | 0.42 – 1.35 | -0.12 | +731.5% | 1.04B | -31.6% | 5 |
| Next quarter | -0.83785 | -2.37 – 0.11 | -0.33 | -153.9% | 516.38M | -43.1% | 5 |
| Current year | -4.68 | -6.14 – -4.04 | -0.48 | -875.5% | 1.78B | -38.1% | 10 |
| Next year | -4.81 | -7.07 – -3.07 | -4.68 | -2.8% | 1.80B | +1.2% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 8, 2026 | BMO Capital | Downgrade | Outperform | Market Perform |
| Aug 31, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 27, 2026 | UBS | Upgrade | Neutral | Buy |
| May 22, 2026 | Bernstein | Initiated | — | Market Perform |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 27, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 31, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 11, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 11, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 11, 2026 | TD Cowen | Maintained | Hold | Hold |
| Mar 11, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 16, 2026 | Goldman Sachs | Upgrade | Neutral | Buy |
| Nov 10, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Oct 23, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 10, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 22, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 8, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 5, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 5, 2025 | B of A Securities | Maintained | Buy | Buy |